RELIEF Clinical Trial

Title: “A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain”

Study Sponsor: Boston Scientific

Principal Investigator: Christopher Rumana, MD

Study Synopsis: To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice.

This is a prospective, multi-center global registry for all commercially approved Boston Scientific neurostimulation systems. Spinal cord stimulation (SCS) is a treatment option for chronic pain that has generally been reserved for patients who have failed multiple, and sometimes all, conservative chronic pain therapies. Study assessments will be required from patients from the baseline up to 36 months post neurostimulation trial. This trial will have up to 4800 enrolled patients and yield up to 3000 subjects with a permanent implant.

Study Status: Open for enrollment.

For more information, contact Lutheria Hollis, CCRC, at (850) 877-5115.

Call Us (850) 877-5115